CONTIXL

This brand name is authorized in Nigeria.

Active ingredients

The drug CONTIXL contains one active pharmaceutical ingredient (API):

1	Tamsulosin UNII 11SV1951MR - TAMSULOSIN HYDROCHLORIDE
	Tamsulosin binds selectively and competitively to post-synaptic α1-adrenoreceptors, prevailingly their subtypes designated α1A and α1D. Thus relaxation of smooth muscles of the prostate and urethra is achieved, which leads to a reduction of tonus and an improvement of the urinary flow.
	Read more about Tamsulosin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-101203	Capsule	Contixl Prolonged Release Capsule 400 mcg CAP 400 mcg 3 x 10's (in PVC/PVDC-Alu blisters)	Prolonged-release capsule, hard. Hard gelatin capsules, no. 3 size with orange body and olive cap containing white to off-white pellets CONTIXL PROLONGED RELEASE CAPSULE 400MCG TAMSULOSIN 400MCG, CORN STARCH, MAGNESIUM STEARATE, CROSCAMELLOSE SODIUM, PURIFIED TALC, MANNITOL A4-101203 Drugs Imported Product 30-10-2024 FIRST J. POCCO PHARMACY LIMITED, No. 89,DENNIS OSADEBE WAY, ASABA, DELTA STATE 08037949861 jpocco47@gmail.com "CAMBRIDGE HEALTHCARE LIMITED, PLOT NO. 257, GIDC, PHASE -1, MODHERA ROAD, MEHSANA - 384002, GUJARAT, INDIA."	27/03/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04CA02	Tamsulosin	G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CA Alpha-adrenoreceptor antagonists
Discover more medicines within G04CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-101203